JP2022552520A5 - - Google Patents

Info

Publication number
JP2022552520A5
JP2022552520A5 JP2022522022A JP2022522022A JP2022552520A5 JP 2022552520 A5 JP2022552520 A5 JP 2022552520A5 JP 2022522022 A JP2022522022 A JP 2022522022A JP 2022522022 A JP2022522022 A JP 2022522022A JP 2022552520 A5 JP2022552520 A5 JP 2022552520A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
disease
cough
prevention
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022522022A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022552520A (ja
JP7612682B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2020/078856 external-priority patent/WO2021074198A1/en
Publication of JP2022552520A publication Critical patent/JP2022552520A/ja
Publication of JP2022552520A5 publication Critical patent/JP2022552520A5/ja
Application granted granted Critical
Publication of JP7612682B2 publication Critical patent/JP7612682B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022522022A 2019-10-15 2020-10-14 新規なテトラゾール Active JP7612682B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP19203174 2019-10-15
EP19203174.8 2019-10-15
PCT/EP2020/078856 WO2021074198A1 (en) 2019-10-15 2020-10-14 Novel tetrazoles

Publications (3)

Publication Number Publication Date
JP2022552520A JP2022552520A (ja) 2022-12-16
JP2022552520A5 true JP2022552520A5 (https=) 2023-10-24
JP7612682B2 JP7612682B2 (ja) 2025-01-14

Family

ID=68289875

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022522022A Active JP7612682B2 (ja) 2019-10-15 2020-10-14 新規なテトラゾール

Country Status (5)

Country Link
US (1) US12497401B2 (https=)
EP (1) EP4045053B1 (https=)
JP (1) JP7612682B2 (https=)
CN (1) CN114555601B (https=)
WO (1) WO2021074198A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7612682B2 (ja) * 2019-10-15 2025-01-14 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 新規なテトラゾール
AU2022257269A1 (en) 2021-04-14 2023-08-17 Boehringer Ingelheim International Gmbh 3H,4H-THIENO[2,3-d]PYRIMIDIN-4-ONE DERIVATIVES AS TRPA1 INHIBITORS
IT202100015098A1 (it) 2021-06-09 2022-12-09 Flonext S R L Composto antagonista del canale trpa1 per uso in patologie degenerative della retina
WO2025167992A1 (zh) * 2024-02-08 2025-08-14 宜昌人福药业有限责任公司 一种非选择性阳离子通道trpa1拮抗剂及其用途

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996040256A1 (en) 1995-06-07 1996-12-19 G.D. Searle & Co. Method to treat cardiofibrosis with a combination of an angiotensin ii antagonist and spironolactone
US7754709B2 (en) 2003-06-10 2010-07-13 Solvay Pharmaceuticals Bv Tetracyclic thiophenepyrimidinone compounds as inhibitors of 17β hydroxysteroid dehydrogenase compounds
EP2411395B1 (en) 2009-03-23 2013-05-29 Glenmark Pharmaceuticals S.A. Furopyrimidinedione derivatives as trpa1 modulators
PE20140234A1 (es) 2010-12-20 2014-03-08 Glenmark Phamaceuticals S A Compuestos de 2-amino-4-ariltiazol como antagonistas de trpa1
CA2836856A1 (en) 2011-06-13 2012-12-20 Glenmark Pharmaceuticals, S.A. Treatment of respiratory disorders using trpa1 antagonists
WO2015155306A1 (en) 2014-04-11 2015-10-15 Almirall, S.A. New trpa1 antagonists
JP6573968B2 (ja) 2014-08-11 2019-09-11 ハイドラ バイオサイエンシズ インコーポレイテッドHydra Biosciences,Inc. TRPC5調節因子としての、精神神経障害の処置のためのチエノおよびフロ[2,3−d]ピリミジン−2,4[1H,3H]−ジオン誘導体
US12006328B2 (en) 2014-11-18 2024-06-11 Emory University Thieno[2,3-d]pyrimidin-4-one derivatives as NMDAR modulators and uses related thereto
WO2016133888A1 (en) 2015-02-16 2016-08-25 Biota Pharmaceuticals, Inc. Compounds for treating respiratory syncytial virus infections
WO2017060488A1 (en) * 2015-10-09 2017-04-13 Almirall, S.A. New trpa1 antagonists
CN111201234A (zh) 2017-07-17 2020-05-26 南京瑞捷医药科技有限公司 新型化合物及其作为acc抑制剂的用途
JP7612682B2 (ja) * 2019-10-15 2025-01-14 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 新規なテトラゾール
CA3153115A1 (en) 2019-10-15 2021-04-22 Boehringer Ingelheim International Gmbh Thienopyrimidones as trpa1 inhibitors
JP7376706B2 (ja) 2019-10-15 2023-11-08 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Trpa1阻害剤としてのチエノピリミドン
CN116348471B (zh) 2020-10-14 2025-10-31 勃林格殷格翰国际有限公司 作为trpa1抑制剂的四唑衍生物
AU2021363101A1 (en) 2020-10-14 2023-03-23 Boehringer Ingelheim International Gmbh Tetrazole derivatives as TRPA1 inhibitors
AU2022257269A1 (en) 2021-04-14 2023-08-17 Boehringer Ingelheim International Gmbh 3H,4H-THIENO[2,3-d]PYRIMIDIN-4-ONE DERIVATIVES AS TRPA1 INHIBITORS

Similar Documents

Publication Publication Date Title
JP2022552520A5 (https=)
JP2024516371A5 (https=)
JP2006526031A5 (https=)
JP2020500862A5 (https=)
JP2017186358A5 (https=)
JP2019507781A5 (https=)
JP2009502743A5 (https=)
JP2018507914A5 (https=)
JP2025161856A5 (https=)
JP2020097577A5 (https=)
JP2018534348A5 (https=)
JP2023166406A5 (https=)
EP2277505A3 (en) Mucoactive agents for treating a pulmonary disease
JP2024540183A5 (https=)
JP2019519533A5 (https=)
JP2015517489A5 (https=)
JP2009535352A5 (https=)
JP2012504133A5 (https=)
JP2004534850A5 (https=)
JP2005518413A5 (https=)
JP2009545527A5 (https=)
JP2023534131A5 (https=)
JP2022537047A5 (https=)
JP2024541569A5 (https=)
JPWO2023195530A5 (https=)